Millennium Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
Other funds holding RCKT
RI
NM
MC
Millennium Management's RCKT Position: Q2 2026 in Review
Millennium Management increased its Rocket Pharmaceuticals (RCKT) stake by 28% in Q2 2026, buying an estimated $2.93M and bringing the position to 4,000,344 shares worth $13.7M. The position accounts for 0.01% of the portfolio, ranked #1986.
Millennium Management first reported a position in RCKT in Q4 2015 and has held it in 36 quarters since. The position peaked at $22.2M in Q3 2024. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.
- Millennium Management held 4,000,344 shares of Rocket Pharmaceuticals worth $13.7M as of Q2 2026.
- Millennium Management bought 882,220 Rocket Pharmaceuticals shares in Q2 2026, an estimated $2.93M.
- Rocket Pharmaceuticals made up 0.01% of Millennium Management's portfolio in Q2 2026, its #1986 holding.
- Millennium Management first reported a position in Rocket Pharmaceuticals in Q4 2015 and has held it in 36 quarters since.
- Millennium Management's Rocket Pharmaceuticals position peaked at $22.2M in Q3 2024.
- 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.